Skip to main content
Midas Edge

Inspire Medical Systems, Inc.

For the period ended Sep 30, 2026. Filed Nov 2, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 2, 2026

INSP$64.33+0.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Statements of Stockholders' Equity

Consolidated Statements of Stockholders' Equity (unaudited)

(in thousands, except share amounts)

Nine Months Ended September 30, 2026
Common Stock
SharesPar ValueAdditionalPaid-InCapitalAccumulatedOtherComprehensiveIncome (Loss)AccumulatedDeficitTotalStockholders'Equity
Balance at December 31, 202528,579,015$29$927,159$464$(146,492)$781,160
Stock options exercised, net2,343—109——109
Vesting of restricted stock units and performance stock units, net219,816—(7,591)——(7,591)
Issuance of common stock865—83——83
Stock-based compensation expense——30,689——30,689
Other comprehensive loss, net of tax———(816)—(816)
Net loss————(11,294)(11,294)
Balance at March 31, 202628,802,03929950,449(352)(157,786)792,340
Stock options exercised, net10,119—403——403
Vesting of restricted stock units and performance stock units, net35,753—(685)——(685)
Issuance of common stock1,475—84——84
Issuance of common stock for employee stock purchase plan57,835—2,193——2,193
Stock-based compensation expense——31,226——31,226
Other comprehensive loss, net of tax———(293)—(293)
Net earnings————314314
Balance at June 30, 202628,907,221$29$983,670$(645)$(157,472)$825,582
Stock options exercised, net8,566—313——313
Vesting of restricted stock units and performance stock units, net24,114—(749)——(749)
Issuance of common stock1,654—84——84
Stock-based compensation expense——26,917——26,917
Other comprehensive loss, net of tax———(804)—(804)
Net loss————(24,394)(24,394)
Balance at September 30, 202628,941,555$29$1,010,235$(1,449)$(181,866)$826,949

Consolidated Statements of Stockholders' Equity (unaudited)

(in thousands, except share amounts)

Nine Months Ended September 30, 2025
Common Stock
Shares · Par Value · AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome · AccumulatedDeficit · TotalStockholders'Equity
Balance at December 31, 202429,740,176$30$981,043$536$(291,914)$689,695
Stock options exercised, net73,491—6,441——6,441
Vesting of restricted stock units and performance stock units, net199,778—(19,192)——(19,192)
Issuance of common stock390—69——69
Stock-based compensation expense——31,056——31,056
Accelerated share repurchase of common stock(103,886)—————
Share repurchase of common stock(442,649)(1)(75,008)——(75,009)
Other comprehensive loss, net of tax———(309)—(309)
Net earnings————2,9922,992
Balance at March 31, 202529,467,30029924,409227(288,922)635,743
Stock options exercised, net43,691—2,174——2,174
Vesting of restricted stock units and performance stock units, net28,487—(1,732)——(1,732)
Issuance of common stock490—73——73
Issuance of common stock for employee stock purchase plan29,509—3,255——3,255
Stock-based compensation expense——41,724——41,724
Other comprehensive income, net of tax———169—169
Net loss————(3,592)(3,592)
Balance at June 30, 202529,569,477$29$969,903$396$(292,514)$677,814
Stock options exercised, net11,685—144——144
Vesting of restricted stock units and performance stock units, net23,995(1,224)(1,224)
Issuance of common stock633—84——84
Stock-based compensation expense——29,467——29,467
Share repurchase of common stock(552,423)—(50,000)——(50,000)
Other comprehensive income, net of tax———243—243
Net earnings————9,9329,932
Balance at September 30, 202529,053,367$29$948,374$639$(282,582)$666,460
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.